COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome

Boot, Erik, Booij, Jan, Zinkstok, Janneke R., Baas, Frank, Swillen, Ann, Owen, Michael John ORCID: https://orcid.org/0000-0003-4798-0862, Murphy, Declan G., Murphy, Kieran C., Linszen, Don H. and Van Amelsvoort, Thérèse A. 2011. COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome. Synapse 65 (9) , pp. 967-970. 10.1002/syn.20932

Full text not available from this repository.

Abstract

Although catechol-O-methyltransferase (COMT) activity evidently affects dopamine function in prefrontal cortex, the contribution is assumed less significant in striatum. We studied whether a functional polymorphism in the COMT gene (Val158Met) influences striatal D2/3R binding ratios (D2/3R BPND) in 15 adults with 22q11 deletion syndrome and hemizygous for this gene, using single photon emission computed tomography and the selective D2/3 radioligand [123I]IBZM. Met hemizygotes had significantly lower mean D2/3R BPND than Val hemizygotes. These preliminary data suggest that low COMT activity may affect dopamine levels in striatum in humans and this may have implications for understanding the contribution of COMT activity to psychiatric disorders.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	Q Science > QH Natural history > QH426 Genetics
Uncontrolled Keywords:	catechol-O-methyltransferase, dopamine, SPECT, striatum, D2/3 receptor binding
Publisher:	Wiley
ISSN:	0887-4476
Last Modified:	19 Oct 2022 10:01
URI:	https://orca.cardiff.ac.uk/id/eprint/22973

Citation Data

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item